Skip to main content
OpenTrials
Completed

NCT Number: NCT04078841

Treating Post-Lyme Disease Syndrome With Acetogenins

To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Post-Lyme Disease Syndrome (PLDS) Bacterial Infections Bacterial Infections and Mycoses Borrelia Infections Chronic Disease Disease Attributes Gram-Negative Bacterial Infections Infections Lyme Disease Pathologic Processes Pathological Conditions, Signs and Symptoms Post-Infectious Disorders Post-Lyme Disease Syndrome Spirochaetales Infections Tick-Borne Diseases Vector Borne Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Optimal Health Research

Salt Lake City, Utah, 84117, United States

About this study

To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS). After failure of antibiotic therapy to relive persistent symptoms of Lyme Disease, the use of Acetogenins to elevate Post-Lyme Disease Syndrome.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • A positive Western Blot for Lyme Disease that has been treated with antibiotics but the symptoms persist post treatment.
  • Must be able to swallow and mixed powder drink.

-

Exclusion criteria

  • Non Positive Western Blot test.
  • Positive Western Blot test where the indivual has not been treated with antibiotics.

-

Treatment and study plan

ReaLife+ (RLP)

Dietary Supplement

RLP is a dietary supplement containing Acetogenins, vitamin, mineral and amino acids.

Inert Brown powder

Other

Brown powder Inert brown powder to look similar to RLP

Primary outcomes

  1. Blood test

    Time frame: 3 months

    Western Blot showing "negative"

  2. PROMIS Fatigue Scale

    Time frame: 3 months

    Self reported fatigue level changes as measured by the Patient-Reported Outcomes Measurement Information System, Fatigue Scale.

Sponsors and collaborators

Lead sponsor

Optimal Health Research

Other

Registry information

Official study title

Using ReaLife+ to Treat Post-Lyme Disease Syndrome

Important dates

Study start
2019
Primary completion
2019
Study completion
2020
First posted
Sep 6, 2019
Registry last updated
Feb 11, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.